JP2011522822A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522822A5
JP2011522822A5 JP2011512479A JP2011512479A JP2011522822A5 JP 2011522822 A5 JP2011522822 A5 JP 2011522822A5 JP 2011512479 A JP2011512479 A JP 2011512479A JP 2011512479 A JP2011512479 A JP 2011512479A JP 2011522822 A5 JP2011522822 A5 JP 2011522822A5
Authority
JP
Japan
Prior art keywords
formula
compound
prevention
treatment
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011512479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/003427 external-priority patent/WO2009148620A2/en
Publication of JP2011522822A publication Critical patent/JP2011522822A/ja
Publication of JP2011522822A5 publication Critical patent/JP2011522822A5/ja
Pending legal-status Critical Current

Links

JP2011512479A 2008-06-06 2009-06-05 エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体 Pending JP2011522822A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5968608P 2008-06-06 2008-06-06
US61/059,686 2008-06-06
PCT/US2009/003427 WO2009148620A2 (en) 2008-06-06 2009-06-05 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions

Publications (2)

Publication Number Publication Date
JP2011522822A JP2011522822A (ja) 2011-08-04
JP2011522822A5 true JP2011522822A5 (enExample) 2012-07-19

Family

ID=41398731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512479A Pending JP2011522822A (ja) 2008-06-06 2009-06-05 エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体

Country Status (6)

Country Link
US (1) US20090312437A1 (enExample)
EP (1) EP2303249A4 (enExample)
JP (1) JP2011522822A (enExample)
AU (1) AU2009255626A1 (enExample)
CA (1) CA2727018A1 (enExample)
WO (1) WO2009148620A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
US20090130101A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
US8512961B2 (en) * 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
EP2323641A4 (en) * 2008-06-13 2012-06-20 Bionovo Inc NYASOL AND ANALOGUE THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR-BETA-MEDIATED ILLNESSES
US20100069480A1 (en) * 2008-09-03 2010-03-18 Bionovo, Inc. A Delaware Corporation Methods and compositions for the treatment of cancer
CN103118688B (zh) * 2010-10-14 2016-04-13 天津中医药大学 锁阳化学成分作为植物雌激素的新用途
CN104058946B (zh) * 2014-06-30 2017-02-08 重庆第二师范学院 具有抗肿瘤活性的大黄素过渡金属配合物、制备方法及其应用
CN106153813A (zh) * 2016-08-29 2016-11-23 贵州信邦制药股份有限公司 骨痛药酒中大黄素的鉴别方法
CN106370767A (zh) * 2016-08-29 2017-02-01 贵州信邦制药股份有限公司 关节克痹丸中虎杖的鉴别方法
WO2019009354A1 (ja) * 2017-07-05 2019-01-10 株式会社沖縄リサーチセンター 排尿障害改善用組成物
CN110031588B (zh) * 2019-03-26 2021-02-09 浙江金大康动物保健品有限公司 一种畜禽抗病毒颗粒的一板多药味快速薄层鉴别方法
EP3953712A1 (en) * 2019-04-10 2022-02-16 Universität Zürich A method for determining the likelihood of a patient being responsive to cancer immunotherapy
CN109942650B (zh) * 2019-04-29 2022-04-15 广西壮族自治区中医药研究院 一种欧鼠李苷的提取方法及其医药用途
CN110057960A (zh) * 2019-05-07 2019-07-26 哈尔滨快好药业有限公司 一种颈康胶囊中何首乌的质量及安全性控制方法
KR102250681B1 (ko) * 2019-10-11 2021-05-11 부경대학교 산학협력단 결명자에서 분리된 화합물을 포함하는 우울증의 예방 또는 치료용 조성물
JP7610353B2 (ja) * 2020-03-03 2025-01-08 小林製薬株式会社 女性ホルモン様作用剤

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2616328B1 (fr) * 1987-06-12 1990-03-02 Moet Hennessy Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
GB9103075D0 (en) * 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
KR100221762B1 (ko) * 1996-10-29 1999-09-15 이승기 에모딘의 항암제로서의 용도
AU746946B2 (en) * 1997-03-21 2002-05-09 Shiseido Company Ltd. Immunopotentiators
MC2441A1 (fr) * 1997-07-31 1998-03-11 Exsymol Sa Composition cosmétique utile notamment pour le blanchiment de la peau et agent inhibiteur de la mélanogénèse comprenant une telle composition cosmétique
FR2784294B1 (fr) * 1998-10-12 2000-11-17 Oreal Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
US6304825B1 (en) * 1999-01-19 2001-10-16 Xerox Corporation Rotary encoder error compensation system and method for photoreceptor surface motion sensing and control
FR2791573B1 (fr) * 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
DE10031650A1 (de) * 2000-06-29 2002-01-17 Schwabe Willmar Gmbh & Co Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden
US6238707B1 (en) * 2000-10-11 2001-05-29 Zhang Chun Herbal hormone balance composition
US6551627B1 (en) * 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
US20030125265A1 (en) * 2001-05-09 2003-07-03 Mien-Chie Hung Anti-estrogen receptor agents for chemotherapy
US6855344B2 (en) * 2001-07-17 2005-02-15 Integrated Chinese Medicine Holdings, Ltd. Compositions and methods for prostate and kidney health and disorders, an herbal preparation
US6750248B2 (en) * 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
JP4474518B2 (ja) * 2003-03-28 2010-06-09 学校法人日本大学 ２−ヒドロキシイソフラバノンデヒドラターゼをコードするポリヌクレオチドおよびその応用
US20070122501A1 (en) * 2003-06-27 2007-05-31 Hong Kong University Of Science And Technology Formulations containing astragalus extracts and uses thereof
JP5300195B2 (ja) * 2003-09-08 2013-09-25 ジェニオウス バイオメド インターナショナル インコーポレイテッド 癌治療のための植物性薬品抽出物の組成物
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20050118290A1 (en) * 2003-12-02 2005-06-02 University Of Singapore Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
US7288021B2 (en) * 2004-01-07 2007-10-30 Cabot Microelectronics Corporation Chemical-mechanical polishing of metals in an oxidized form
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
CA2565721C (en) * 2004-05-06 2015-10-06 Bioresponse, L.L.C. Diindolymethane formulations for the treatment of leiomyomas
JP4939425B2 (ja) * 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド 乳癌の治療反応の予後および予測の分子指標
WO2006062876A2 (en) * 2004-12-09 2006-06-15 Merck & Co., Inc. Estrogen receptor modulators
CA2588566A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Estrogenic extracts of morus alba and uses thereof
WO2006065599A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US8293726B2 (en) * 2005-12-02 2012-10-23 Vianova Labs, Inc. Treatment of cancer and other diseases
RS55630B1 (sr) * 2005-12-21 2017-06-30 Janssen Pharmaceutica Nv Triazolopiridazini kao modulatori tirozin kinaze
US7381432B2 (en) * 2006-09-19 2008-06-03 Jose Angel Olalde Menopause disorder synergistic phyto-nutraceutical composition
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
EP2323641A4 (en) * 2008-06-13 2012-06-20 Bionovo Inc NYASOL AND ANALOGUE THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR-BETA-MEDIATED ILLNESSES

Similar Documents

Publication Publication Date Title
RU2342145C2 (ru) Селективные модуляторы рецептора эстрогена в комбинации с эстрогенами
CN1239160C (zh) 共轭雌激素和醋酸甲羟孕酮的组合物及其用途
JP6866560B2 (ja) エステトロール成分を含有する口腔内崩壊性投与単位
MX338290B (es) Tratamiento de enfermedad de alzheimer, perdida de cognición, perdida de memoria y demencia con precursores de esteroides sexuales en conbinación con moduladores selectivos del receptor de estrógenos.
JP7053478B2 (ja) Ｆｘｒアゴニストを使用するための方法
JP2010180236A5 (enExample)
CA2721191A1 (en) Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
IL314360B2 (en) Method for the synthesis of thyroid hormone analogs and their polymorphs
IL292245B1 (en) Polymorphic forms of rad1901-2hcl
JP2015520233A5 (enExample)
JP2010077149A (ja) エストロゲン補充療法を受けている女性のホルモン不足の治療方法
WO2007144152A2 (en) Extended step-down estrogen regimen
JP3954386B2 (ja) 抗エストロゲン作用を有する４−フルオルアルキル−２ｈ−ベンゾピラン
JP2016540021A (ja) エステトロール成分を含有する口腔内崩壊固体単位剤形
JP2011068653A5 (enExample)
JP2012506872A5 (enExample)
JP2008512426A5 (enExample)
CN1555266A (zh) 激素替代疗法
WO2010040286A1 (zh) 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
JP2018138594A (ja) オナプリストン多形体及び使用方法
CN101823956B (zh) 非诺贝特酸二异丙胺盐、其制备方法, 药物组合物及其用途
CN1192145A (zh) 最大限度地减少骨损失的方法
CN106580902A (zh) 一种依匹哌唑口崩片及其制备方法
JP2015178480A (ja) 骨減少性疾患改善剤およびびわ抽出物製造方法
CN1929835A (zh) 芳香酶抑制剂治疗－相关的骨质疏松症的治疗